Please Wait
Applying Filters...
menu
    • menu
    FDA’s December 2025 OPOE list features 784 prescription drugs, 73 OTC drugs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector 2025 highlights: FDA approves pill version of Novo’s Wegovy; BioMarin acquires Amicus for US$ 4.8 bn

    Stock Recap
    #PipelineProspector

    Menu

    Kallidinogenase

    ACTIVE PHARMA INGREDIENTS

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    30/12/2025 Changzhou Qianhong Bio-Pharma
    China
    		 Medica Korea Co., Ltd. 20240313-209-J-1408(A) kallidinogenase 2024-03-26 Changzhou Qianhong Bio-pharma Co., Ltd. China No. 192 Huanghe West Road, Xinbei District, Changzhou, Jiangsu, China
    30/12/2025 Changzhou Qianhong Bio-Pharma
    China
    		 Ilhwa Co., Ltd. 20240313-209-J-1408 kallidinogenase 2024-03-13 Changzhou Qianhong Bio-pharma Co., Ltd. China No. 192 Huanghe West Road, Xinbei District, Changzhou, Jiangsu, China
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.